Express Scripts 2014 Annual Report Download - page 11

Download and view the complete annual report

Please find page 11 of the 2014 Express Scripts annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 116

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116

9
Express Scripts 2014 Annual Report
processingthroughtheprescriptiondrugbenefit.Weprovideourclientsatoolsetdesignedtomanagetotalspecialtyspend
regardlessofwhichbenefitthedrugisprocessedthrough.Ourcapabilitiesincludeguaranteeingsavingsthroughmedical
benefitmanagementservices,ensuringthesafeandappropriateuseofhigh-costspecialtydrugs,redirectingpatientsand
medicationstothelowest-costandmostappropriatechannel,verifyingclaimsarepaidatthecontractedrate,improving
opportunitiestoachieverebatesand,whereclinicallyappropriate,movingdrugcoveragefrommedicaltopharmacybenefitand
tolower-costsitesofcare.
Retail Network Pharmacy Administration.Wecontractwithretailpharmaciestoprovideprescriptiondrugsto
membersofthepharmacybenefitplanswemanage.IntheUnitedStates,PuertoRicoandtheVirginIslands,wenegotiatewith
pharmaciestodiscountthepricesatwhichtheyprovidedrugstomembersandmanagenationalandregionalnetworksthatare
responsivetoclientpreferencesrelatedtocostcontainment,convenienceofaccessformembersandnetworkperformance.We
alsomanagenetworksofpharmaciescustomizedfororunderdirectcontractwithspecificclients.Inaddition,wehave
contractedpharmacyprovidernetworkstocomplywithCMSaccessrequirementsfortheMedicarePartDPrescriptionDrug
Program(“MedicarePartD”).
Allretailpharmaciesinourpharmacynetworkscommunicatewithusonlineandinrealtimetoprocess
prescriptiondrugclaims.Whenamemberofaplanpresentshisorheridentificationcardatanetworkpharmacy,thenetwork
pharmacistsendscertainspecifiedmember,prescriberandprescriptioninformationinanindustry-standardformatthroughour
systems,whichprocesstheclaimandsendaresponsebacktothepharmacywithrelevantinformationtoprocessthescript.
Benefit Design Consultation.Weconsultwithourclientsonhowbesttostructureandleveragethepharmacy
benefittomeettheirobjectivesforaffordablebenefits,providingaccesstoneededcarewhileeliminatingwaste.Wesupportour
clientsindeterminingthescopeandconditionsofcoverageandofferingincentivesformembersandtheirproviders.Weadopt
programsthatdrivesafer,moreeffectiveandmoreaffordableuseofprescriptiondrugs.
Drug Utilization Review.Ourelectronicclaimsprocessingsystemenablesustoimplementsophisticated
interventionprogramstomanageprescriptiondrugutilization.Thesystemcanalertthepharmacisttodrugsafetyconcerns,
genericsubstitutionandtherapeuticinterventionopportunities,aswellasformularyadherenceissues,andcanalsoadminister
priorauthorization,steptherapyprotocolprogramsanddrugquantitymanagementatthetimeaclaimissubmittedfor
processing.Ourclaimsprocessingsystemalsogeneratesadatabaseofdrugutilizationinformationthatcanbeaccessedatthe
timeaprescriptionisdispensed,onaretrospectivebasistoanalyzeutilizationtrendsandprescribingpatternsformore
intensivemanagementofthedrugbenefit,andonaprospectivebasistohelpsupportpharmacistsindrugtherapymanagement
decisions.
Drug Formulary Management. Formulariesarelistsofdrugstowhichbenefitdesignisapplied.Incombination
withthebenefitdesign,theformularymaybeusedtocommunicateplanpreferencesandtodeterminewhetheraparticulardrug
iscovered.Ifcovered,theformularywilldeterminetowhatextentitiscovered.Ourformularymanagement servicessupport
clientsinchoosingandmaintainingformulariesthatbestmeetplanobjectivesforaccess,safetyandaffordability.Further,our
formularymanagementservicesassistpatientsandphysiciansinchoosingclinicallyappropriate,cost-effectivedrugsfora
givencondition,formularyandplandesign.
Weadministermanydifferentformulariesonbehalfofourclients,includingstandardformulariesdevelopedand
offeredbyExpressScriptsandcustomformulariesforwhichweplayamorelimitedrole.Themajorityofourclientsselect
standardformularies,governedbyourNationalPharmacy&Therapeutics(“P&T”)Committee,apanelcomposedof
independentphysiciansandpharmacistsinactiveclinicalpractice,representingavarietyofspecialtiesandpracticesettingsand
typicallywithmajoracademicaffiliations.Mostclientschooseformulariesdesignedtobeusedwithfinancialincentives,such
asthree-tierco-payments,whichdrivepreferentialselectionofplan-preferredgenericsandbrandeddrugsovertheirnon-
formularyalternatives.Someclientsselectclosedformularies,inwhichcoverageisavailableonlyforthosedrugslistedonthe
formulary.
ExpressScripts’standardformulariesaregovernedbydecisionsoftheNationalP&TCommittee.Indeveloping
theseformularies,theforemostconsiderationisthesafetyandeffectivenessofthedrugsbeingevaluatedinrelationtoavailable
alternatives.Inmakingformularyrecommendations,theP&TCommitteeconsidersthedrug’ssafetyandefficacy,withoutany
informationonorconsiderationofthecostofthedrug,includinganydiscountorrebatearrangementwemightnegotiatewith
themanufacturer.Thisprocessisdesignedtoensuretheclinicalrecommendationisnotaffectedbyourfinancialarrangements.
WefullycomplywiththeP&TCommittee’sclinicalrecommendationsregardingdrugsthatmustbeincludedorexcludedfrom
theformularybasedontheirassessmentofsafetyandefficacy.WheretheNationalP&TCommitteeisindifferentastowhether
aparticulardrugmustbeincludedorexcludedfromtheformulary,thedrugsareevaluatedonaneconomicbasisinrelationto
alternativestodeterminetheoptimalcompositionoftheformulary.
5